Expected Launch Next Year
Curocell Submits Korean Approval Application for ‘Rimcarto’
Curocell announced on the 30th that it has submitted a marketing authorization application to the Ministry of Food and Drug Safety (MFDS) for its next-generation CAR-T therapy, 'Rimcarto…